TomEnterprise AB 13D and 13G filings for DiaMedica Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-07-30 5:31 pm Purchase | 2025-07-23 | 13G | DiaMedica Therapeutics Inc. DMAC | TomEnterprise AB | 8,383,577 16.280% | 4,057,142 (+93.78%) | Filing |
| 2023-06-27 4:12 pm Purchase | 2023-06-23 | 13G | DiaMedica Therapeutics Inc. DMAC | TomEnterprise AB | 4,326,435 11.400% | 1,470,588 (+51.49%) | Filing |
| 2022-07-12 1:24 pm Purchase | 2022-07-08 | 13G | DiaMedica Therapeutics Inc. DMAC | TomEnterprise AB | 2,855,847 10.800% | 304,827 (+11.95%) | Filing |
| 2021-10-08 4:14 pm Purchase | 2021-09-28 | 13G | DiaMedica Therapeutics Inc. DMAC | TomEnterprise AB | 2,551,020 9.600% | 2,551,020 (New Position) | Filing |